Search Our Scientific Publications & Authors

Publications
find publications by category +
Translate page:

BMSCs attenuate hepatic fibrosis in autoimmune hepatitis through regulation of LMO7-AP1-TGFβ signaling pathway.

Authors:
Z-K Chen D-Z Chen C Cai L-L Jin J Xu Y-L Tu X-Z Huang J-L Xu M-Z Chen F-B Xue X-L Lan X-D Wang Y-L Ge H -L Sun Y-P Chen

Eur Rev Med Pharmacol Sci 2021 Feb;25(3):1600-1611

Department of Infectious Diseases, the First Affiliated Hospital of Wenzhou Medical University, Zhejiang Provincial Key Laboratory for Accurate Diagnosis and Treatment of Chronic Liver.

Objective: In a previous study, we reported that transplantation of bone mesenchymal stem cells (BMSCs) significantly attenuated liver damage in a mouse autoimmune hepatitis (AIH) model. Moreover, expression of the LIM domain protein, LMO7, correlated positively with the invasive capacity of hepatoma cells. However, whether LMO7 plays a role in inflammation and fibrosis of AIH remains unknown. This investigation aimed to explore the effect of BMSC transplantation on LMO7 and the role of LMO7 in hepatic fibrosis.

Materials And Methods: S100-induced murine AIH and LPS-induced hepatocyte injury models were successfully established. Three doses of BMSCs were injected into AIH mice via the tail vein. LPS-treated AML12 cells were co-cultured with BMSCs in vitro. Small interfering (si) LMO7 RNA and T5224 (a specific inhibitor of AP-1) were used to demonstrate the relationship between LMO7-AP1-transforming growth factor (TGF)-β.

Results: Pathological examination and serum alanine and aspartate aminotransferase levels indicated that liver damage was notably ameliorated in the BMSC-treated mice. LMO7 level was upregulated, while AP-1 and TGF-β levels were downregulated upon intervention with BMSCs. AP-1 expression was upregulated in the siLMO7 group, whereas TGF-β level was downregulated in the T5224 group when compared to those in the control group.

Conclusions: BMSC transplantation significantly limits liver fibrosis and upregulates the expression of LMO7. LMO7 inhibits the TGF-β pathway by inhibiting AP-1. This implies that BMSCs are a potential means of treating liver fibrosis. This approach has important implications for the treatment of AIH and other fibrotic diseases.

Download full-text PDF

 Source
http://dx.doi.org/10.26355/eurrev_202102_24870DOI Listing
February 2021

Publication Analysis

Top Keywords

liver fibrosis
8
autoimmune hepatitis
8
bmsc transplantation
8
liver damage
8
lmo7
8
bmscs
6
aih
5
lmo7-ap1-transforming growth
4
relationship lmo7-ap1-transforming
4
demonstrate relationship
4
ap-1 demonstrate
4
inhibitor ap-1
4
rna t5224
4
t5224 specific
4
specific inhibitor
4
ap-1
4
pathological examination
4
aspartate aminotransferase
4
aminotransferase levels
4
levels indicated
4

Keyword Occurance

Similar Publications

Sound therapy can modulate the functional connectivity of the auditory network.

Authors:
Han Lv Qian Chen Xuan Wei Chunli Liu Pengfei Zhao Zhaodi Wang Zhenghan Yang Shusheng Gong Hong You Zhenchang Wang

Prog Neuropsychopharmacol Biol Psychiatry 2021 Apr 7:110323. Epub 2021 Apr 7.

Department of Radiology, Beijing Friendship Hospital, Capital Medical University, Beijing 100050, China. Electronic address:

The functional connectivity of the auditory network is considered to be important in the development of tinnitus. We hypothesized that sound therapy, as a commonly used effective treatment for tinnitus, can modulate the functional connectivity of the auditory network. In this prospective observational study, we recruited 27 tinnitus patients who had undergone 12 weeks of sound therapy and 27 matched healthy controls. Read More

View Article and Full-Text PDF
April 2021
Similar Publications

Factors associated with phosphatidylethanol (PEth) sensitivity for detecting unhealthy alcohol use: An individual patient data meta-analysis.

Authors:
Judith A Hahn Pamela M Murnane Eric Vittinghoff Winnie R Muyindike Nneka I Emenyonu Robin Fatch Gabriel Chamie Jessica E Haberer Joel M Francis Saidi Kapiga Karen Jacobson Bronwyn Myers Marie Claude Couture Ralph J DiClemente Jennifer L Brown Kaku So-Armah Mark Sulkowski Gregory M Marcus Sarah Woolf-King Robert L Cook Veronica L Richards Patricia Molina Tekeda Ferguson David Welsh Mariann R Piano Shane A Phillips Scott Stewart Majid Afshar Kimberly Page Kathleen McGinnis David A Fiellin Amy C Justice Kendall Bryant Richard Saitz

Alcohol Clin Exp Res 2021 Apr 10. Epub 2021 Apr 10.

Department of Community Health Sciences, Boston University, School of Public Health, Section of General Internal Medicine, Boston University, School of Medicine and Boston Medical Center, Grayken Center on Addiction, Boston Medical Center, Boston, MA, USA.

Background: Objective measurement of alcohol consumption is important for clinical care and research. Adjusting for self-reported alcohol use, we conducted an individual participant data (IPD) meta-analysis to examine factors associated with the sensitivity of phosphatidylethanol (PEth), an alcohol metabolite, among persons self-reporting unhealthy alcohol consumption.

Methods: We identified 21 eligible studies and obtained 4073 observations from 3085 participants with Alcohol Use Disorders Identification Test - Consumption (AUDIT-C) positive scores (≥3 for women and ≥4 for men) and PEth measurements. Read More

View Article and Full-Text PDF
April 2021
Similar Publications

Identification of transcriptomic signatures and crucial pathways involved in non-alcoholic steatohepatitis.

Authors:
Weiwei He Caoxin Huang Xiaofang Zhang Dongmei Wang Yinling Chen Yan Zhao Xuejun Li

Endocrine 2021 Apr 10. Epub 2021 Apr 10.

Xiamen Diabetes Institute, The First Affiliated Hospital of Xiamen University, Xiamen, China.

Purpose: Our study aimed to uncover the crucial genes and functional pathways involved in the development of non-alcoholic steatohepatitis (NASH).

Methods: Liver transcriptome datasets were integrated with Robust rank aggregation (RRA) method, and transcriptomic signatures for NASH progression and fibrosis severity in NAFLD were developed. The functions of transcriptomic signatures were explored by multiple bioinformatic analyses, and their diagnostic role was also evaluated. Read More

View Article and Full-Text PDF
April 2021
Similar Publications

Treatment for bleeding oesophageal varices in people with decompensated liver cirrhosis: a network meta-analysis.

Authors:
Danielle Roberts Lawrence Mj Best Suzanne C Freeman Alex J Sutton Nicola J Cooper Sivapatham Arunan Tanjia Begum Norman R Williams Dana Walshaw Elisabeth Jane Milne Maxine Tapp Mario Csenar Chavdar S Pavlov Brian R Davidson Emmanuel Tsochatzis Kurinchi Selvan Gurusamy

Cochrane Database Syst Rev 2021 Apr 10;4:CD013155. Epub 2021 Apr 10.

Division of Surgery and Interventional Science, University College London, London, UK.

Background: Approximately 40% to 95% of people with liver cirrhosis have oesophageal varices. About 15% to 20% of oesophageal varices bleed within about one to three years after diagnosis. Several different treatments are available, including, among others, endoscopic sclerotherapy, variceal band ligation, somatostatin analogues, vasopressin analogues, and balloon tamponade. Read More

View Article and Full-Text PDF
April 2021
Similar Publications

Restless legs syndrome among subjects having chronic liver disease: A systematic review and meta-analysis.

Authors:
Ravi Gupta Rohit Gupta Niraj Kumar Vikram Singh Rawat Jan Ulfberg Richard Putnam Allen

Sleep Med Rev 2021 Mar 11;58:101463. Epub 2021 Mar 11.

Department of Neurology, John Hopkins University, Baltimore, MD, USA.

Sleep disturbances are commonly reported in patients with chronic liver disease (CLD). Changes in quality of sleep in patients with CLD could be related to multiple factors viz., elevated levels of tryptophan, histamine, and increased turnover of dopamine in caudate-putamen and cingulate cortex. Read More

View Article and Full-Text PDF
March 2021
Similar Publications